These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 33678791

  • 1. [A Case of Thyroid Dysfunction and Isolated Adrenocorticotropin Deficiency after Nivolumab Therapy for Malignant Melanoma].
    Nishio K, Okada Y, Kurozumi A, Tanaka Y.
    J UOEH; 2021; 43(1):97-102. PubMed ID: 33678791
    [Abstract] [Full Text] [Related]

  • 2. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A, Yamamoto M, Morita M, Tanaka S, Kanazawa I, Yamauchi M, Kaneko S, Sugimoto T.
    BMC Endocr Disord; 2019 Feb 19; 19(1):25. PubMed ID: 30782163
    [Abstract] [Full Text] [Related]

  • 3. Nivolumab-induced hypothyroidism followed by isolated ACTH deficiency.
    Martins Machado C, Almeida Santos L, Barroso A, Oliveira MJ.
    BMJ Case Rep; 2019 Aug 28; 12(8):. PubMed ID: 31466960
    [Abstract] [Full Text] [Related]

  • 4. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N, Kobayashi M, Ohashi K, Ito R, Ikeda Y, Kawaguchi G, Yoneoka Y, Hasegawa G, Takada T.
    J Med Case Rep; 2019 Mar 26; 13(1):88. PubMed ID: 30909965
    [Abstract] [Full Text] [Related]

  • 5. Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency.
    Katakura Y, Kimura T, Kusano T, Tatsumi F, Iwamoto Y, Sanada J, Fushimi Y, Shimoda M, Kohara K, Nakanishi S, Kaku K, Mune T, Kaneto H.
    Front Endocrinol (Lausanne); 2021 Mar 26; 12():722586. PubMed ID: 34712202
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes.
    Peiró I, Palmero R, Iglesias P, Díez JJ, Simó-Servat A, Marín JA, Jiménez L, Domingo-Domenech E, Mancho-Fora N, Nadal E, Villabona C.
    Endocrine; 2019 Jun 26; 64(3):605-613. PubMed ID: 30805887
    [Abstract] [Full Text] [Related]

  • 9. Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.
    Ariyasu H, Inaba H, Ota T, Yamaoka H, Furukawa Y, Iwakura H, Doi N, Yamamoto Y, Akamizu T.
    In Vivo; 2018 Jun 26; 32(2):345-351. PubMed ID: 29475919
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sequential occurrence of primary and secondary hypothyroidism during treatment with nivolumab: pitfalls in immuno-oncological therapy and endocrinological diagnostic procedures.
    Ansorge C, Seufert J, Meiss F, von Bubnoff D.
    J Dtsch Dermatol Ges; 2018 Dec 26; 16(12):1483-1485. PubMed ID: 30411844
    [No Abstract] [Full Text] [Related]

  • 13. Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma.
    Mishima Y, Fukaishi T, Inase N, Isogai S.
    Intern Med; 2019 Mar 01; 58(5):693-697. PubMed ID: 30449786
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma.
    Sakaguchi C, Yano S, Ashida K, Wada N, Ohe K, Nagata H, Matsuda Y, Sakamoto S, Sakamoto R, Ohnaka K, Uchi H, Furue M, Nomura M, Ogawa Y.
    Am J Case Rep; 2019 Jan 25; 20():106-110. PubMed ID: 30679413
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
    Yonezaki K, Kobayashi T, Imachi H, Yoshimoto T, Kikuchi F, Fukunaga K, Sato S, Ibata T, Yamaji N, Lyu J, Dong T, Murao K.
    J Med Case Rep; 2018 Jun 19; 12(1):171. PubMed ID: 29914537
    [Abstract] [Full Text] [Related]

  • 20. Late-onset hypophysitis after discontinuation of nivolumab treatment for advanced skin melanoma: a case report.
    Antoniou S, Bazazo G, Röckl L, Papadakis M, Berg C.
    BMC Endocr Disord; 2021 Sep 20; 21(1):191. PubMed ID: 34544399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.